BRISTOL-MYER's BUSPAR (BUSPIRONE) WILL BE LAUNCHED IN EARLY DECEMBER; APPROVED LABELING CALLS DRUG "LESS SEDATING", "NO POTENTIAL FOR ABUSE"

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".